课题基金 / 基金详情

Anti-Müllerian Hormone and Cardiovascular Risk in Males with Chronic Kidney Disease

Anti-Müllerian Hormone and Cardiovascular Risk in Males with Chronic Kidney Disease
男性慢性肾病患者的抗苗勒氏管激素和心血管风险
批准号:
485991
负责人:
Larsen Nicole
金额:
$1.27万
依托单位:
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-12-01 至 2023-12-01

项目摘要

项目成果

Larsen Nicole的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
One in 8 Canadian males have Chronic Kidney Disease (CKD), and the prevalence is increasing. Cardiovascular disease is the leading cause of death in individuals with CKD, and males are at increased risk compared to females. Prevention and treatment of car
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anti-Müllerian hormone and cardiovascular risk in males with chronic kidney disease: A protocol.
  • 批准号:
    481028
  • 项目类别:
  • 资助金额:
    $0.05万
  • 财政年份:
    2023
  • 负责人:
    Larsen Nicole
  • 依托单位:
Anti-Müllerian Hormone and Cardiovascular Risk in Males with Chronic Kidney Disease: Preliminary Findings From a Cross-Sectional Study
  • 批准号:
    493131
  • 项目类别:
  • 资助金额:
    $0.11万
  • 财政年份:
    2023
  • 负责人:
    Larsen Nicole
  • 依托单位:
海外基金